Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study.
Mangarule S, Prashanth S, Kawade A, Ravi MD, Padmavathi IV, Palkar S, Tripathi VN, Singh R, Maurya M, Mitra M, Shetty RS, Kompithra RZ, Dhaded SM, Epari V, Moureau A, Jayanth MV, Varghese K, Ravinuthala S, Kukian D, Patnaik BN, Noriega F. Mangarule S, et al. Among authors: moureau a. Vaccine X. 2022 Sep 13;12:100216. doi: 10.1016/j.jvacx.2022.100216. eCollection 2022 Dec. Vaccine X. 2022. PMID: 36164460 Free PMC article.
Association of rotavirus strains and severity of gastroenteritis in Indian children.
Saluja T, Dhingra MS, Sharma SD, Gupta M, Kundu R, Kar S, Dutta AK, Silveira MD, Singh JV, Kamath VG, Chaudhary A, Rao V, Ravi MD, Murthy K, Arumugam R, Moureau A, Prasad R, Patnaik BN. Saluja T, et al. Among authors: moureau a. Hum Vaccin Immunother. 2017 Mar 4;13(3):711-716. doi: 10.1080/21645515.2016.1238994. Epub 2016 Sep 29. Hum Vaccin Immunother. 2017. PMID: 27686522 Free PMC article.
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India.
Mangarule S, Palkar S, Mitra M, Ravi MD, Dubey AP, Moureau A, Jayanth MV, Patel DM, Ravinuthala S, Jagga SR, Patnaik BN, Jordanov E, Noriega F. Mangarule S, et al. Among authors: moureau a. Vaccine X. 2022 Jan 10;10:100137. doi: 10.1016/j.jvacx.2021.100137. eCollection 2022 Apr. Vaccine X. 2022. PMID: 35462885 Free PMC article.
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India.
Mangarule S, Palkar S, Mitra M, Ravi MD, Singh R, Moureau A, Jayanth MV, Patel DM, Ravinuthala S, Patnaik BN, Jordanov E, Noriega F. Mangarule S, et al. Among authors: moureau a. Vaccine X. 2022 Jul 2;11:100190. doi: 10.1016/j.jvacx.2022.100190. eCollection 2022 Aug. Vaccine X. 2022. PMID: 35899104 Free PMC article.
Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
Aloysia D'Cor N, Siddaiah P, Mohapatra S, Dhaded SM, I V P, Kar S, V N T, Muley P, Chhatwal J, Patnaik BN, Vidor E, Moureau A, Patel DM, Midde VJ, Jagga SR, Peesapati S, Noriega F. Aloysia D'Cor N, et al. Among authors: moureau a. PLoS One. 2023 Aug 15;18(8):e0284898. doi: 10.1371/journal.pone.0284898. eCollection 2023. PLoS One. 2023. PMID: 37582114 Free PMC article. Clinical Trial.
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
Pichon S, Moureau A, Petit C, Kirstein JL, Sheldon E, Guinet-Morlot F, Minutello AM. Pichon S, et al. Among authors: moureau a. Vaccine. 2024 Apr 11;42(10):2553-2559. doi: 10.1016/j.vaccine.2023.11.052. Epub 2023 Dec 16. Vaccine. 2024. PMID: 38105138 Free article.
Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction.
Plennevaux E, Sabchareon A, Limkittikul K, Chanthavanich P, Sirivichayakul C, Moureau A, Boaz M, Wartel TA, Saville M, Bouckenooghe A. Plennevaux E, et al. Among authors: moureau a. Vaccine. 2016 May 23;34(24):2707-12. doi: 10.1016/j.vaccine.2016.04.028. Epub 2016 Apr 18. Vaccine. 2016. PMID: 27102820 Clinical Trial.
Dengue serotype-specific seroprevalence among 5- to 10-year-old children in India: a community-based cross-sectional study.
Garg S, Chakravarti A, Singh R, Masthi NR, Goyal RC, Jammy GR, Ganguly E, Sharma N, Singh MM, Ferreira G, Moureau A, Ojha S, Nealon J; DNG10 study group. Garg S, et al. Among authors: moureau a. Int J Infect Dis. 2017 Jan;54:25-30. doi: 10.1016/j.ijid.2016.10.030. Epub 2016 Nov 4. Int J Infect Dis. 2017. PMID: 27825949 Free article.
46 results